A Certificate of Analysis (COA) is available for each batch.
The next fourteen years were spent figuring out how much to give, how often, how long, what are the results, side effects and complications
Efruxifermin (EFX), a long-acting Fc-FGF21 fusion protein, administered for 16 weeks to patients with NASH substantially reduces liver fat and ALT, and improves liver histology: analysis of a randomized, placebo-controlled, phase 2a study (balanced) [abstract]
Ganne-Carrie N, Medini A, Coderc E, Seror O, Christidis C, Grimbert S, Trinchet JC, Beaugrand M
Tailored Treatment Plan: Based on your unique needs, we will create a personalized treatment plan to optimize the benefits of intravenous glutathione therapy specifically for you
This might cause low blood sugar, or hypoglycemia